PortalPublikationenTitration to target dose of bisoprolol vs. carvedilol in eld...

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.

Standard

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial. / Düngen, Hans-Dirk; Apostolovic, Svetlana; Inkrot, Simone; Tahirovic, Elvis; Töpper, Agnieszka; Mehrhof, Felix; Prettin, Christiane; Putnikovic, Biljana; Neskovic, Aleksandar N; Krotin, Mirjana; Sakac, Dejan; Lainscak, Mitja; Edelmann, Frank; Wachter, Rolf; Rau, Thomas; Eschenhagen, Thomas; Doehner, Wolfram; Anker, Stefan D; Waagstein, Finn; Herrmann-Lingen, Christoph; Gelbrich, Goetz; Dietz, Rainer; Investigators, CIBIS-ELD; Failure, Project Multicentre Trials In The Competence Network Heart.

in: EUR J HEART FAIL, Jahrgang 13, Nr. 6, 6, 2011, S. 670-680.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Düngen, H-D, Apostolovic, S, Inkrot, S, Tahirovic, E, Töpper, A, Mehrhof, F, Prettin, C, Putnikovic, B, Neskovic, AN, Krotin, M, Sakac, D, Lainscak, M, Edelmann, F, Wachter, R, Rau, T, Eschenhagen, T, Doehner, W, Anker, SD, Waagstein, F, Herrmann-Lingen, C, Gelbrich, G, Dietz, R, Investigators, CIBIS-ELD & Failure, PMTITCNH 2011, 'Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.', EUR J HEART FAIL, Jg. 13, Nr. 6, 6, S. 670-680. <http://www.ncbi.nlm.nih.gov/pubmed/21429992?dopt=Citation>

APA

Düngen, H-D., Apostolovic, S., Inkrot, S., Tahirovic, E., Töpper, A., Mehrhof, F., Prettin, C., Putnikovic, B., Neskovic, A. N., Krotin, M., Sakac, D., Lainscak, M., Edelmann, F., Wachter, R., Rau, T., Eschenhagen, T., Doehner, W., Anker, S. D., Waagstein, F., ... Failure, P. M. T. I. T. C. N. H. (2011). Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial. EUR J HEART FAIL, 13(6), 670-680. [6]. http://www.ncbi.nlm.nih.gov/pubmed/21429992?dopt=Citation

Vancouver

Düngen H-D, Apostolovic S, Inkrot S, Tahirovic E, Töpper A, Mehrhof F et al. Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial. EUR J HEART FAIL. 2011;13(6):670-680. 6.

Bibtex

@article{4263359835bb4bfdb8573bfe248933a4,
title = "Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.",
abstract = "Various beta-blockers with distinct pharmacological profiles are approved in heart failure, yet they remain underused and underdosed. Although potentially of major public health importance, whether one agent is superior in terms of tolerability and optimal dosing has not been investigated. The aim of this study was therefore to compare the tolerability and clinical effects of two proven beta-blockers in elderly patients with heart failure.",
keywords = "Humans, Male, Female, Treatment Outcome, Europe, Double-Blind Method, Dose-Response Relationship, Drug, Adrenergic beta-Antagonists/adverse effects/*therapeutic use, *Aged, Bisoprolol/adverse effects/*therapeutic use, Carbazoles/adverse effects/*therapeutic use, Forced Expiratory Volume/drug effects, Heart Failure/*drug therapy/physiopathology, Heart Rate/drug effects, Propanolamines/adverse effects/*therapeutic use, Humans, Male, Female, Treatment Outcome, Europe, Double-Blind Method, Dose-Response Relationship, Drug, Adrenergic beta-Antagonists/adverse effects/*therapeutic use, *Aged, Bisoprolol/adverse effects/*therapeutic use, Carbazoles/adverse effects/*therapeutic use, Forced Expiratory Volume/drug effects, Heart Failure/*drug therapy/physiopathology, Heart Rate/drug effects, Propanolamines/adverse effects/*therapeutic use",
author = "Hans-Dirk D{\"u}ngen and Svetlana Apostolovic and Simone Inkrot and Elvis Tahirovic and Agnieszka T{\"o}pper and Felix Mehrhof and Christiane Prettin and Biljana Putnikovic and Neskovic, {Aleksandar N} and Mirjana Krotin and Dejan Sakac and Mitja Lainscak and Frank Edelmann and Rolf Wachter and Thomas Rau and Thomas Eschenhagen and Wolfram Doehner and Anker, {Stefan D} and Finn Waagstein and Christoph Herrmann-Lingen and Goetz Gelbrich and Rainer Dietz and CIBIS-ELD Investigators and Failure, {Project Multicentre Trials In The Competence Network Heart}",
year = "2011",
language = "English",
volume = "13",
pages = "670--680",
journal = "EUR J HEART FAIL",
issn = "1388-9842",
publisher = "Oxford University Press",
number = "6",

}

RIS

TY - JOUR

T1 - Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.

AU - Düngen, Hans-Dirk

AU - Apostolovic, Svetlana

AU - Inkrot, Simone

AU - Tahirovic, Elvis

AU - Töpper, Agnieszka

AU - Mehrhof, Felix

AU - Prettin, Christiane

AU - Putnikovic, Biljana

AU - Neskovic, Aleksandar N

AU - Krotin, Mirjana

AU - Sakac, Dejan

AU - Lainscak, Mitja

AU - Edelmann, Frank

AU - Wachter, Rolf

AU - Rau, Thomas

AU - Eschenhagen, Thomas

AU - Doehner, Wolfram

AU - Anker, Stefan D

AU - Waagstein, Finn

AU - Herrmann-Lingen, Christoph

AU - Gelbrich, Goetz

AU - Dietz, Rainer

AU - Investigators, CIBIS-ELD

AU - Failure, Project Multicentre Trials In The Competence Network Heart

PY - 2011

Y1 - 2011

N2 - Various beta-blockers with distinct pharmacological profiles are approved in heart failure, yet they remain underused and underdosed. Although potentially of major public health importance, whether one agent is superior in terms of tolerability and optimal dosing has not been investigated. The aim of this study was therefore to compare the tolerability and clinical effects of two proven beta-blockers in elderly patients with heart failure.

AB - Various beta-blockers with distinct pharmacological profiles are approved in heart failure, yet they remain underused and underdosed. Although potentially of major public health importance, whether one agent is superior in terms of tolerability and optimal dosing has not been investigated. The aim of this study was therefore to compare the tolerability and clinical effects of two proven beta-blockers in elderly patients with heart failure.

KW - Humans

KW - Male

KW - Female

KW - Treatment Outcome

KW - Europe

KW - Double-Blind Method

KW - Dose-Response Relationship, Drug

KW - Adrenergic beta-Antagonists/adverse effects/therapeutic use

KW - Aged

KW - Bisoprolol/adverse effects/therapeutic use

KW - Carbazoles/adverse effects/therapeutic use

KW - Forced Expiratory Volume/drug effects

KW - Heart Failure/drug therapy/physiopathology

KW - Heart Rate/drug effects

KW - Propanolamines/adverse effects/therapeutic use

KW - Humans

KW - Male

KW - Female

KW - Treatment Outcome

KW - Europe

KW - Double-Blind Method

KW - Dose-Response Relationship, Drug

KW - Adrenergic beta-Antagonists/adverse effects/therapeutic use

KW - Aged

KW - Bisoprolol/adverse effects/therapeutic use

KW - Carbazoles/adverse effects/therapeutic use

KW - Forced Expiratory Volume/drug effects

KW - Heart Failure/drug therapy/physiopathology

KW - Heart Rate/drug effects

KW - Propanolamines/adverse effects/therapeutic use

M3 - SCORING: Journal article

VL - 13

SP - 670

EP - 680

JO - EUR J HEART FAIL

JF - EUR J HEART FAIL

SN - 1388-9842

IS - 6

M1 - 6

ER -